Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel

Por Ali, Asif, Brown, Victoria, Denley, Simon, Jamieson, Nigel B, Morton, Jennifer P, Nixon, Colin, Graham, Janet S, Sansom, Owen J, Carter, C Ross, McKay, Colin J, Duthie, Fraser R, Oien, Karin A
Publicado em 2014

Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation

Por Gingras, Marie-Claude, Covington, Kyle R., Chang, David K., Donehower, Lawrence A., Gill, Anthony J., Ittmann, Michael M., Creighton, Chad J., Johns, Amber L., Shinbrot, Eve, Dewal, Ninad, Fisher, William E., Pilarsky, Christian, Grützmann, Robert, Overman, Michael J., Jamieson, Nigel B., Van Buren, George, Drummond, Jennifer, Walker, Kimberly, Hampton, Oliver A., Xi, Liu, Muzny, Donna M., Doddapaneni, Harsha, Lee, Sandra L., Bellair, Michelle, Hu, Jianhong, Han, Yi, Dinh, Huyen H., Dahdouli, Mike, Samra, Jaswinder S., Bailey, Peter, Waddell, Nicola, Pearson, John V., Harliwong, Ivon, Wang, Huamin, Aust, Daniela, Oien, Karin A., Hruban, Ralph H., Hodges, Sally E., McElhany, Amy, Saengboonmee, Charupong, Duthie, Fraser R., Grimmond, Sean M., Biankin, Andrew V., Wheeler, David A., Gibbs, Richard A.
Publicado no Cell Rep (2016)